ABPI response to New Treatment Fund extension
The Welsh Minister for Health and Social Services, Vaughan Gething has today confirmed £16m to extend the New Treatment Fund, a scheme to speed up access to new medicines in Wales
The New Treatment Fund has an excellent track record in speeding up people’s access to new, clinically and cost-effective medicines. We’re delighted to see that it will continue into 2022. Ahead of the upcoming Senedd Elections, we’re looking for all political parties to pledge their support for the Fund and to ensure it features in the programme of the next Welsh Government. ABPI Cymru Wales Director Dr Rick Greville
The New Treatment Fund has enabled quicker access to over 265 medicines to treat more than 100 health conditions since it was established by the Welsh Government in 2017. It has cut the average time it takes for newly-recommended medicines to become available to patients by 85 per cent, from 90 to 13 days.
In response, ABPI Cymru Wales Director Rick Greville commented:
“The New Treatment Fund has an excellent track record in speeding up people’s access to new, clinically and cost-effective medicines. We’re delighted to see that it will continue into 2022.
“Ahead of the upcoming Senedd Elections, we’re looking for all political parties to pledge their support for the Fund and to ensure it features in the programme of the next Welsh Government.
“Ensuring access to appropriate treatments at the right time will benefit patients, the NHS and the pharmaceutical industry across Wales.”
- New Treatment Fund
Last modified: 20 September 2023
Last reviewed: 20 September 2023